ONCORE BIOPHARMA
OnCore Biopharma, Inc. is a privately held biotechnology company focused on the research, development, and commercialization of therapies for the treatment of chronic hepatitis B virus (HBV) infection. OnCore has assembled a portfolio of novel product candidates with unique mechanisms of action for the treatment of hepatitis B and is focused on delivering a cure.
ONCORE BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Doylestown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.oncorebiopharma.com
Total Employee:
11+
Status:
Active
Contact:
(215) 489-4928
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
Domain Not Resolving OpenResty Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Shockwave Flash Embed
Similar Organizations
10xBio
10xBio, LLC, a privately-held biotechnology company
Origin
Origin is a privately held, clinical-stage biotechnology company.
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Benu Biopharma
Benu Biopharma Inc.is a “Virtual” business model Company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-10-01 | Enantigen Therapeutics | Enantigen Therapeutics acquired by OnCore Biopharma | N/A |
Official Site Inspections
http://www.oncorebiopharma.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "OnCore Biopharma"
OnCore Biopharma Company Profile 2024: Valuation, …
OnCore Biopharma General Information Description. Provider of oral cure services for patients suffering from hepatitis B infection. The company develops and provides combination therapies that helps in eradication of hepatitis B …See details»
Oncore Biopharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Oncore Biopharma, Inc. of Warminster, PA. Get the latest business insights from Dun & Bradstreet.See details»
OnCore Biopharma Inc - Company Profile and News
OnCore Biopharma, Inc. operates as a biotechnology company. The Company engages in the research, development, and commercialization of therapies for the treatment of chronic …See details»
OnCore Biopharma | White Rose Wiki
¶OnCore Biopharma. OnCore Biopharma was an American pharmaceutical company. ¶ History In January 2015, Tekmira Pharmaceuticals announced it would purchase OnCore in order to …See details»
OnCore Biopharma - Funding, Financials, Valuation & Investors
OnCore Biopharma, Inc. is a privately held biotechnology company. How much funding has this organization raised over time? ShowSee details»
OnCore Biopharma - Company Profile - Tracxn
OnCore Biopharma - Therapies for the treatment of chronic hepatitis B virus (HBV) infection. Acquired by Tekmira Pharmaceuticals. Founded by Patrick Higgins in the year 2012. OnCore …See details»
OnCore Biopharma - Products, Competitors, Financials, Employees ...
Oct 21, 2016 OnCore Biopharma is focused on finding a cure for chronic hepatitis B virus infection. The company's mission is to discover and develop an all-oral cure for patients …See details»
OnCore Biopharma - Crunchbase
OnCore Biopharma, Inc. is a privately held biotechnology company. Start Free TrialSee details»
Tekmira Pharmaceuticals Corporation completed the acquisition …
Mar 3, 2015 Tekmira Pharmaceuticals Corporation (TSX:TKM) entered into an agreement to acquire OnCore Biopharma, Inc. from Roivant Sciences, Inc., Patrick T. Higgins, Michael J. …See details»
OnCore Biopharma Announces Merger Agreement with Tekmira
Palo Alto – January 14, 2015 – Cooley is advising OnCore Biopharma, Inc. on its proposed merger with Tekmira Pharmaceuticals Corporation to create a new leading global company …See details»
OnCore Biopharma, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Tekmira Pharmaceuticals, OnCore Biopharma merge to form …
Jan 12, 2015 Stocks at Tekmira Pharmaceuticals (Nasdaq:TKMR) (TSX:TKM) shot up 43% to $22.59 Monday morning (January 12) after the Burnaby-based company announced it was …See details»
Tekmira Purchases OnCore Biopharma To Find Hep B Cure
Jan 12, 2015 Tekmira Pharmaceuticals stock soared on Monday after the Canadian drugmaker said Sunday that it would buy privately held OnCore Biopharma to bolster its efforts to develop …See details»
OnCore Biopharma - Contacts, Employees, Board Members
OnCore Biopharma has 2 current employee profiles, including Co-Founder and Chief Executive Officer Patrick Higgins. Patrick Higgins Co-Founder and Chief Executive Officer Michael J. …See details»
Oncore Pharma - Craft
Oncore Pharma is a pharmaceutical company specializing in cancer detection. It offers BreastSentry and ColonSentry, proprietary liquid biopsy tests that use gene expression …See details»
OnCore BioPharma acquires Worldwide License to NVP018
Uncover the latest breakthrough in healthcare innovation as OnCore BioPharma secures an exclusive worldwide license to NVP018. Learn more today.See details»
OnCore Biopharma and Tekmira Pharmaceuticals files for merger ...
Feb 5, 2015 “ In September 2014, we [OnCore Biopharma, Inc.] entered into a license agreement with NeuroVive that granted us an exclusive, worldwide, sublicensable license, …See details»
OnCore marks milestones in mission to cure hepatitis B
Nov 12, 2014 DOYLESTOWN, Pa.—OnCore Biopharma has made a series of important steps toward its goal of developing a cure for chronic hepatitis B. During the last couple months, the …See details»
Michael Sofia - Chief Scientific Officer - Crunchbase
Dr. Sofia was one of OnCore Biopharma’s co-founders and served as its Chief Scientific Officer and Head of Research and Development since July 2014. He previously served as President …See details»